Selection standard: studies are included when they materially inform detection time, cutoff performance, analytical method, specimen interpretation, or the calculator's stated limitations.

Download CSV ↓

11 primary studies shown

StudyDesignSpecimenMain focus
Jatlow et al. (2014)Ethylglucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitationsControlled dose-ranging challengeUrineEtG and EtS over time after measured alcohol exposure
Lowe et al. (2015)Determining ethyl glucuronide cutoffs when detecting self-reported alcohol useOutpatient diagnostic performance studyUrine100, 200, 300, 400, and 500 ng/mL over 24–120 hours
McDonell et al. (2015)Using ethyl glucuronide in urine to detect light and heavy drinkingAlcohol-dependent outpatient studyUrineLight and heavy drinking detection over one to five days
van de Luitgaarden et al. (2019)Urinary ethyl glucuronide as an alcohol biomarker in a population studyPopulation cohort analysisUrineSensitivity and specificity at 100 and 500 ng/mL
Böttcher et al. (2008)Evaluation of a new immunoassay for urinary ethyl glucuronide testing400-sample analytical comparisonUrineEtG immunoassay compared with LC-MS
Heltsley et al. (2011)Improved detection of EtG and EtS using high-throughput LC-MS/MSRetrospective diagnostic-accuracy studyUrineImmunoassay positives compared at multiple LC-MS/MS cutoffs
Stewart et al. (2015)Ethyl glucuronide concentrations in hair: a controlled alcohol-dosing study12-week controlled dosing studyHairHair EtG response to repeated measured alcohol exposure
Kintz et al. (2019)Hair EtG alterations accompanying hair growthRepeated hair-segment studyHairChange in EtG concentration as a segment grows
Dumitrascu et al. (2024)Complementarity of PEth in blood and EtG in hair2,340 paired samplesBlood and hairDifferent time frames represented by PEth and hair EtG
Nguyen et al. (2018)Evaluation of methods for EtG, EtS, and PEthAnalytical validation with volunteer samplesBloodDirect alcohol-biomarker measurement by UHPLC-MS/MS
Helander et al. (2012)Monitoring PEth, CDT, and EtG/EtS in outpatient treatmentLongitudinal outpatient monitoringBlood, serum, and urineComplementary detection across biomarkers

How to use this database

Read the study population, collection schedule, specimen, test method, and cutoff before applying a finding. A percentage from an outpatient group or controlled challenge does not become an individual probability without matching conditions.

See the calculator methodology, editorial standards, and research explainers.